Background: Percutaneous coronary intervention (PCI) has increased as the initial revascularization strategy in chronic coronary artery disease. Consequently, more patients undergoing coronary artery bypass grafting (CABG) have history of coronary stent.
Introduction
Despite all scientific evidences and the guidelines for the treatment of chronic coronary artery disease demonstrating the benefits of coronary artery bypass grafting (CABG), especially in patients with multivessel disease, there has been an exponential growth in percutaneous coronary intervention (PCI) with stents 1, 2 . With technological advances and the experience accumulated over the years, the indication for PCI has expanded and procedures in multivessel coronary disease have become more common 3, 4 .
In this so-called "stent era", patients with coronary artery disease and class I indication for CABG are frequently submitted to PCI as initial alternative, before being convinced to surgical treatment 5 . Some studies have shown restenosis rates after PCI with stent, with need of reintervention due to symptom recurrence, ranging from 20% to 40% 6, 7 . More recently, it has been discussed whether previous PCI is a risk factor with negative impact on the outcomes of CABG [8] [9] [10] . A significant inflammatory process and endothelial function abnormalities in the coronary arteries have been related to the treatment with stent, especially when drug-eluting stents were used [11] [12] [13] . However, the actual clinical impact of the presence of stents in the coronary artery in the prognosis of CABG has not been clearly established and it is controversy 14, 15 . The increase in mortality is the main event that can influence changes in the guidelines.
The objective of this study is to assess the impact of previous PCI with stent as risk factor for in-hospital mortality in patients with multivessel chronic coronary artery disease who requiring later surgical treatment for myocardial revascularization.
The Hosmer-Lemeshow goodness-of-fit statistic test was used to compare the observed and predicted mortality with 95% confidence intervals. A well-calibrated model gives corresponding p > 0.05.
Univariate and multivariate logistic regression models were used to identify associated factors and independent preoperative predictors for in-hospital mortality. The variables identified by the univariate analysis with a p value ≤ 0.10 were used to the adjustment of the multivariate logistic regression model (forward procedure).
In an additional effort to minimize the influence from a non-randomized study, a second analysis was performed using the propensity score matching. Patients with prior PCI (study group) were matched with patients without prior PCI (control group), at a 1:1 ratio. After matching, in-hospital mortality was compared between the two groups. Paired samples were also reevaluated using the univariate and multivariate logistic regression tests, in order to control eventual risk factor selection bias.
The analysis was done using two-tailed tests and p <0.05 was considered statistically significant. The SPSS software version 18.0 was used for statistical analysis (SPSS Inc, Chicago, Illinois).
Results

Patients characteristics
From May 2007 to July 2009, 1551 patients were submitted to first time isolated CABG at the Heart Institute University of Sao Paulo Medical School. Four hundred and twenty-nine patients were excluded because they were operated without cardiopulmonary bypass or because they were submitted to PCI during the same hospitalization as the surgical treatment, 15 patients were excluded because they were submitted to vascular procedures associated to CABG and 8 patients were excluded due to incomplete information regarding prior angioplasty. The other 1099 patients were the final study population.
Of the 1099 patients included in the study, 938 (85.3%) patients underwent CABG without previous PCI and 161 (14.6%) patients had previous PCI. Of these, 147 (91.3%) had been submitted to PCI using bare metal stents and 14 (8.7%) using drug-eluting stents. The comparison of patients with and without prior PCI taking into consideration clinical manifestation and preoperative risk factors showed that patients with prior PCI had a more frequent unstable angina (16.1% vs. 9.9%, p=0.019) at the time of hospitalization. There were no others statistical differences between the two groups as to the remaining clinical manifestations and preoperative cardiovascular risk factors (Table 1) .
Surgical treatment
In the intraoperative, patients with prior PCI had lower mean number of revascularized coronary arteries (3.0 vs 3.2 -p=0.446), longer aortic clamping time (76.1 vs. 74.8 minutes, p=0.673) and longer cardiopulmonary bypass time (90.7 vs 85.3 minutes, p=0.584), however, there was no statistical significance. There were also no differences between the two groups regarding the use of left internal thoracic artery (95.2% vs 97.3%, p=0.386).
Patients and methods
A prospective observational design was used. All patients who underwent first-time isolated CABG surgery on cardiopulmonary bypass between May 2007 and July 2009 were included in this study. The study group consisted of 1,099 consecutive patients of mean age 63.6 ± 12.6 years who underwent elective, urgent or emergency CABG surgery. All patients had multivessel atherosclerotic coronary disease. Patients with combined cardiac surgery were excluded. CABG without cardiopulmonary bypass and reoperations were excluded to minimize surgical technique interferences. Patients underwent previous PCI in the same hospitalization as the surgery, were also excluded. All patients were operated at Heart Institute University of Sao Paulo Medical School, a tertiary referral national center and data were prospectively collected, creating a database.
Patient characteristics and preoperative risk factors were analyzed, following the additive European System for Cardiac Operative Risk Evaluation (EuroSCORE) and 2000 BernsteinParsonnet logistic risk model 16, 17 . The correlation of predicted and observed mortality was compared with these two models, for better evaluation. The outcome was in-hospital surgical mortality, defined as death occurring in the time interval between surgery and hospital discharge. This study was approved by the Scientific and Ethics Committee of Heart Institute, University of São Paulo Medical School.
Surgical procedure
CABG was performed with cardiopulmonary bypass, using the classic technique by median sternotomy in all patients. Five hundred UI/Kg of heparin was used to obtain an activated coagulation time greater than 400 seconds. Myocardial protection was achieved with intermittent hyperkalemic antegrade warm blood cardioplegia or with intermittent aortic clamping. Protamine was used for heparin reversal at a ratio of 1:1. At the end of surgery, patients were transferred to the intensive care unit and managed according to the unit protocol.
Patients receiving dual anti-platelet therapy with acetylsalicylic acid and clopidogrel prior surgery were treated as follows: acetylsalicylic acid was discontinued on surgery day and was reintroduced the day following surgery, clopidogrel was discontinued at least 2 to 5 days prior surgery and, if required, it was reintroduced within at least 2 days after surgery.
Statistical analysis
Variables are shown in contingency tables with absolute (n) and relative (%) frequencies. Association among them, taking into consideration the groups with and without prior PCI, was evaluated by the chi-squared test, the likelihood ratio test or Fisher's exact test.
Quantitative variables were shown in tables including the median, and 1 st and 3 rd quartile values. The distribution of variables was evaluated by Mann-Whitney's test.
In-Hospital mortality
The overall mortality according to the additive EuroSCORE and 2000 Bernstein-Parsonnet risk model are showing, respectively, in Table 2 and Table 3 . Patients with prior PCI had a significantly higher in-hospital mortality than those who did not have a prior intervention (9.3% vs. 5.1%, p=0.034). After adjustment with univariate analysis and later on with multivariate logistic regression for differences in clinical manifestations and preoperative risk factors, prior PCI emerged as an independent risk factor for in-hospital mortality after CABG with odds ratio of 1.94 (95% confidence interval 1.02 -3.68; p=0.044). Other factors such as age, pulmonary hypertension, diabetes, congestive heart failure and preoperative intra-aortic balloon pump were also classified ( Table 4) .
Patient matching
Propensity score matching was performed taking into consideration preoperative factors with a greater impact on surgery to match study group (patients with previous PCI) and control group (patients without previous PCI). The following parameters were selected: gender, age, diabetes, systemic hypertension, congestive heart failure, unstable angina, recent myocardial infarction. For this analysis, 161 study group patients were successfully paired with 161 corresponding controls at a ratio of 1;1 (Table 5 ). When in-hospital mortality was compared between the two groups, patients with prior PCI had significantly higher in-hospital mortality after CABG (9.3% vs. 3.1%, p=0.021). After univariate and multivariate analysis with the paired groups, to control eventual variables not selected for the matching, PCI emerged once again as an independent predictor for in-hospital mortality after CABG with odds ratio of 3.46 (95% confidence interval 1.10-10.93; p=0.034) ( Table 6 ).
Discussion
Impact of prior PCI on in-hospital mortality after CABG Cardiovascular surgeons have more and more often been faced with patients referred for CABG after a successful previous PCI. This study clearly showed, based on a database created for a prospective analysis with adjustment of risk factors, that previous PCI is an independent risk factor for in-hospital mortality after CABG.
Mortality risk factors after cardiac surgery have been studied since the late 80s. Initially only using associations and later with risk stratification models 18, 19 . Many variables, including PCI at the same hospitalization, have been studied and known for a long time as in-hospital mortality predictors after CABG 16, 17, 20 . The influence of previous PCI on CABG has been observed for cardiac surgeons in daily practice. However, it has not been extensively studied and only recently, it has been taken into account more seriously.
In 1995, Johnson et al 21 observed negative impact of a previous PCI on CABG. Comparing 234 patients successfully submitted to angioplasty who later required CABG, they observed that surgical risk at the time of surgery was 4.0%, significantly higher than the 2.8% prior angioplasty (p=0.04). In 1996, Jones et al 22 in extensive review of seven large databases with 172,184 patients underwent CABG were the first to identify previous PCI as a risk factor. At the time, it was classified as level 2, i.e., not clearly related to mortality after surgery. In 1998, Kalaycioglu et al 23 in a propensity score matching with 80 patients underwent CABG observed worse outcomes in the group of patients with previous coronary angioplasty. More recently, Hassan et al 8 in a large study with 6504 patients underwent CABG (919 patients with a previous PCI), clearly demonstrated that previous PCI is an independent predictor for in-hospital mortality after CABG, odds ratio of 1.93 (p=0.003). However, nowadays still have doubt if previous PCI is a risk factor for patients who undergoing CABG.
In the last years, there is an increasing number of interventional procedures using stents in intermediate risk patients as well as in patients with more severe multivessel coronary disease, which used to be considered inadequate for PCI 3, 4, 24 . As consequence, there are an increasing number of patients who have been submitted to PCI with stents before being finally referred for CABG. In the literature, this incidence ranges from 10% to 20% [8] [9] [10] . From our study group, 161 patients (14.6%) had previous PCI. In this context, it is important to reassess the clinical relevance of previous PCI and the prognostic value of risks in patients who may require later CABG.
Recent report, with post hoc analysis, patients with history of PCI had worse prognosis after CABG and an increase in cardiovascular events during clinical follow-up 25 . Bonaros et al 26 confirmed these data in study with 306 patients with previous PCI who were matched with similar group without PCI prior to CABG. Patients with previous PCI had higher inhospital mortality (4.4% vs. 2.4%, p<0.001).
In the present study, the analysis of 1099 consecutive patients underwent CABG on cardiopulmonary bypass the overall hospital mortality was 5.7%. This observed mortality reflect the high complexity presented in tertiary service of national reference and it was comparable with predicted mortality based on the additive EuroSCORE and 2000 Bernstein-Parsonnet logistic risk model 27, 28 . The mortality was greater in patients with a history of previous PCI (9.3% vs 5.1%, p<0.034). Logistic regression models indicated that previous PCI with stent was an independent predictor for in-hospital mortality after CABG with an odds ratio of 1.94 (p=0.044). Propensity score matching confirmed previous PCI as a risk factor for in-hospital mortality after CABG (odds ratio of 3.46, p=0.034).
Even though several studies have shown that the previous PCI using stents is risk factor for in-hospital mortality after CABG, this correlation is still controversial. Some groups believe there is no correlation between previous PCI and subsequent CABG 14 . Others have found this correlation only in patients receiving multiple coronary interventions or in diabetic patients 9, [29] [30] [31] . Yap et al 14 analyzed 13,184 patients (1,457 with history of PCI) underwent CABG and did not find an association between previous PCI and early or mid term mortality (odds ratio of 1.11, p=0.41). Thielmann et al 29 analyzed 2626 patients undergoing CABG and found an association between previous PCI and hospital mortality, however, it was only significant in the presence of multiple previous PCIs (odds ratio of 2.24; p<0.001). Massoud et al in multicenter study with almost 30,000 patients confirmed the history of multiple previous PCIs as risk factor for hospital mortality after CABG (odds ratio of 2.02; p=0.0005). In a sub-analysis with 749 diabetic patients, Thielmann et al 31 , observed the association of hospital mortality after CABG with odds ratio of 2.87 (p=0.03) for diabetic patients with a history of previous PCI. In our study group (with previous PCI), 90 patients (56.0%) did not have diabetes and 136 patients (84.5%) had only one previous PCI, even so previous PCI was an independent risk factor. This risk had similar impact as diabetes (odds ratio of 1.86, p=0.028) and chronic renal failure (odds ratio of 4.80, p=0.029), risk factors which have long been known and accepted by the medical community.
Negative influence mechanism
There are several possible causes that may explain the negative impact of previous PCI using stents on CABG:
1-One of them might be stent thrombosis, which takes place more frequently in the first six months after the procedure, and mainly when antiplatelet drugs are discontinued early on to carry out surgery. This thrombotic risk is greater when more than one stent is used, with long stents, stents placed in bifurcations, drug-eluting stents, diabetic patients and in renal failure 32 . In our casuistic, this could explain the cause of approximately 1/3 of the patients operated on within less than 12 months of the PCI.
2 -Another cause might be the number of coronary anastomoses or incomplete revascularization in this group of patients. The most common reasons are occluded coronary arteries or those with multiple stents. Incomplete revascularization may lead to postoperative events such as myocardial infarct and death 33 . In our casuistic, patients with previous PCI had a lower number of coronary anastomosis per patient (3.0 vs. 3.2 in the group without a previous intervention), however there was no statistical difference.
3 -The need to perform coronary anastomosis more distally than usual (as a result of the presence of stents in the mid third of the arteries) may also affect surgery. In this region, arteries have a smaller diameter, greater flow resistance and it is more difficulty to perform coronary anastomosis. This is a mechanic cause, related to the surgical technique, which is difficult to quantify and assess, but definitely plays a major role in the early outcomes of the surgical treatment.
4 -A fourth cause may be the presence of multiple coronary interventions, impairing native blood flow by collaterals causing micro myocardial infarctions. As a consequence, there is more flow resistance of the grafts and lower myocardial irrigation 9, 34 . In our experience, most of the patients (84.5%) had only one previous PCI and this fact could be the cause of only 15% of the patients.
5 -The severity of the progression of coronary atherosclerotic disease may justify the greater mortality. Currently, patients undergoing PCI with a stent have more severe atherosclerotic disease, but not as severe as those undergoing surgical treatment. When treatment fails, these patients are referred for surgical revascularization, however the atherosclerotic disease is then more severe and diffuse 35 . In our casuistic, preoperative clinical factors and the presence of left main lesion were similar between the two groups, which leads to the conclusion that the presence of the stent may have worsened the progression of atherosclerotic disease and delayed the optimal time for surgical treatment.
6 -More recently, endothelial abnormalities caused by the presence of stents have been studied. There is evidence indicating the coronary stents cause lesions in the arterial wall, leading to endothelial dysfunction with a chronic inflammatory response and platelet and neutrophil activation. The inflammatory and proliferative abnormalities are not limited to the treated coronary. It affects other coronary arteries, surrounding tissues, including the myocardium, causing adverse cardiovascular effects. Endothelial abnormalities may also render coronary anastomosis more difficult, affecting the perviousness of the grafts [11] [12] [13] . This is common in bare metal stents and is even more intense in drug-eluting stents 13 . In our casuistic, only 8% of the patients had a previous intervention with drug-eluting stents. If on one hand, there are evidences that drug-eluting stents cause greater inflammatory and chronic response and therefore may further increase surgical risk, on the other hand they may reduce the need of reinterventions and decrease the number of patients requiring CABG after PCI. This association should be further studied.
The mechanism associated with worse prognostic after CABG in patients with previous PCI is multifactorial and probably is caused by a chronic inflammatory reaction, endothelial dysfunction, myocardial ischemic events and changes or difficulty of the surgical technique 15, 36 . Critical analysis and larger and more comprehensive studies should be carried out to establish this association and its respective mechanisms.
Study limitations
This type of study cannot be randomized and the comparison between groups with and without previous PCI has clear limitations, especially regarding the different sample sizes. Even if the propensity score matching is used, the analysis is not ideal, since it depends on selected variables for matching. The type of previous PCI was also not detailed. It was not known whether there was any other procedure in addition to stent implantation or whether there was any other complication. Different causes for surgical treatment indication were also not separated among patients with a previous PCI, such as restenosis, occlusion, thrombosis or disease progression.
Conclusion
Previous PCI is an independent risk factor for in-hospital mortality in patients with multivessel coronary artery disease who requiring later CABG for coronary artery disease. The cardiac surgeons have to be mindful of this, just as they are already had with other factors, such as renal failure and diabetes.
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